Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases

Barbara E. Ostrov

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

In recent decades, innovative strategies to treat patients with inflammatory, immunologically based diseases have advanced in concert with our increased understanding of molecular immunology. Recognition of the spectrum and pathophysiology of autoimmune and autoinflammatory disorders has allowed for the development of cutting-edge therapies for such patients. In this review, key immunotherapeutic approaches for treating inflammatory autoimmune disorders, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as genetic autoinflammatory diseases, such as cryopyrin associated periodic syndromes, are addressed. Indications, risks and additional considerations in the use of these agents are reviewed.

Original languageEnglish (US)
Pages (from-to)777-802
Number of pages26
JournalImmunological Investigations
Volume44
Issue number8
DOIs
StatePublished - Nov 17 2015

All Science Journal Classification (ASJC) codes

  • Immunology

Fingerprint Dive into the research topics of 'Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases'. Together they form a unique fingerprint.

  • Cite this